DNA hypomethylation is prevalent even in low-grade breast cancers

Hypomethylation of some portions of the genome and hypermethylation of others are very frequent attributes of human cancer. We previously showed that cancer-associated DNA hypomethylation often involves satellite 2 (Sat2), the main DNA component of the large juxtacentromeric (centromere-adjacent) heterochromatin of chromosome 1. In this study, we compared methylation of Sat2 and centromeric satellite DNA (Sat?) as well as overall genomic methylation in 41 breast adenocarcinomas of known tumor grade and stage, 16 non-neoplastic breast tissues (mostly fibroadenomas), and a variety of normal somatic tissue controls. The cancers were significantly hypomethylated at Sat2 relative to the fibroadenomas or normal somatic tissues and at Sat? relative to the normal somatic tissues. However, unlike Sat2, Sat? did not display significant differences in methylation between the cancers and the non-neoplastic breast tissues. Therefore, hypomethylation at Sat2 is a much better marker of breast cancer than is Sat? hypomethylation. There was a significant association of Sat2 hypomethylation with global DNA hypomethylation in the cancers but not with tumor grade, stage, axillary lymph node involvement, or hormone receptor status. Extensive cancer-associated hypomethylation of juxtacentromeric satellite DNA and global DNA hypomethylation were common even in grade-1 or stage-1 carcinomas, which suggests that demethylation of the genome is an early event in breast carcinogenesis.

[1]  Peter W. Laird,et al.  DNA Hypomethylation and Ovarian Cancer Biology , 2004, Cancer Research.

[2]  M. Ehrlich.  The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. , 2003, Clinical immunology.

[3]  L. Mariani,et al.  DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. , 2003, Oncology reports.

[4]  D. Kidron,et al.  Application of comparative genomic hybridization in search for genetic aberrations in fibroadenomas of the breast. , 2003, Cancer genetics and cytogenetics.

[5]  P. Arveux,et al.  Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer. , 2003, Archives of surgery.

[6]  Christian B. Woods,et al.  Satellite DNA hypomethylation in karyotyped Wilms tumors. , 2003, Cancer genetics and cytogenetics.

[7]  P. Laird,et al.  Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.

[8]  S. Hirohashi,et al.  Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. , 2002, The American journal of pathology.

[9]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[10]  U. Lehmann,et al.  Quantitative assessment of promoter hypermethylation during breast cancer development. , 2002, The American journal of pathology.

[11]  M. Kitajima,et al.  Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences , 2002, Oncogene.

[12]  F. Wright,et al.  Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas–Implications for tumor biology and potential clinical utility , 2001, Oncogene.

[13]  W. Lau,et al.  Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. , 2001, The American journal of pathology.

[14]  D. Heimburger,et al.  Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. , 2001, Human pathology.

[15]  N. Davidson,et al.  DNA methylation in breast cancer. , 2001, Endocrine-related cancer.

[16]  Y. Liaw,et al.  Genome-wide hypomethylation in hepatocellular carcinogenesis. , 2001, Cancer research.

[17]  H Ishii,et al.  Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.

[18]  M. Ehrlich,et al.  DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients , 2000, Cytogenetic and Genome Research.

[19]  S. Groshen,et al.  Progressive increases in de novo methylation of CpG islands in bladder cancer. , 2000, Cancer research.

[20]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[21]  Philip H. Ramsey.  Nonparametric Statistical Methods , 1974, Technometrics.

[22]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Huang,et al.  CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer , 1999, Nature Genetics.

[24]  R. Löwer,et al.  DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas , 1999, British Journal of Cancer.

[25]  M. Ehrlich,et al.  Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. , 1999, Cancer genetics and cytogenetics.

[26]  M. Ehrlich,et al.  Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.

[27]  S. Baylin,et al.  Hypomethylation of pericentromeric DNA in breast adenocarcinomas , 1998, International journal of cancer.

[28]  S. Weitzman,et al.  Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer , 1998, Oncogene.

[29]  M. Ehrlich,et al.  DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.

[30]  H. Magdelenat,et al.  DNA hypomethylation in breast cancer: an independent parameter of tumor progression? , 1997, Cancer genetics and cytogenetics.

[31]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[32]  M. Ehrlich,et al.  Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. , 1997, Cytogenetics and cell genetics.

[33]  A. Giuliano,et al.  Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma , 1994, Cancer.

[34]  F. Ledeist,et al.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. , 1993, Human molecular genetics.

[35]  E. Viégas-Péquignot,et al.  Specific induction of uncoiling and recombination by azacytidine in classical satellite-containing constitutive heterochromatin. , 1993, Cytogenetics and cell genetics.

[36]  H. Willard,et al.  Chromosome-specific alpha satellite DNA from human chromosome 1: hierarchical structure and genomic organization of a polymorphic domain spanning several hundred kilobase pairs of centromeric DNA. , 1987, Genomics.

[37]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[38]  M. Ehrlich,et al.  Tissue-specific differences in DNA methylation in various mammals. , 1983, Biochimica et biophysica acta.

[39]  F. Grosveld,et al.  The sequence GGCmCGG is resistant to MspI cleavage. , 1983, Nucleic acids research.

[40]  A. Feinberg,et al.  Hypomethylation of ras oncogenes in primary human cancers. , 1983, Biochemical and biophysical research communications.

[41]  M. Ehrlich,et al.  Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. , 1982, Nucleic acids research.

[42]  J. Hindley,et al.  Cloning of human satellite III DNA: different components are on different chromosomes. , 1979, Nucleic acids research.